Skip to main content
Erschienen in: Skeletal Radiology 10/2017

28.06.2017 | Case Report

Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune–Albright syndrome

verfasst von: Alessandro Corsi, Ernesto Ippolito, Pamela G. Robey, Mara Riminucci, Alan Boyde

Erschienen in: Skeletal Radiology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Bisphosphonates (BPs) are currently used in the treatment of diverse bone diseases including fibrous dysplasia of bone (FD). In pediatric patients, a radiographic consequence of cyclical administration of BPs is the development of apo-, epi-, and meta-physeal sclerotic bands, otherwise known as zebra lines, which result from the temporary inhibition of osteoclastic activity at the time of drug treatment. We report here on a child with McCune–Albright syndrome (FD in addition to hyperfunctioning endocrinopathies and skin hyperpigmentation) treated with cyclical intravenous infusions of pamidronate in which conventional radiography, contact microradiography, histology, and backscattered electron image analysis demonstrated that zebra lines formed only where bone was normal, were arrested at the boundary between FD-unaffected and FD-affected bone where bone is sclerotic, and were absent within the undermineralized FD bone. Moreover, in spite of the treatment, the FD lesions continued to expand. This case report is unique because no previously published studies correlated the radiographic and the histologic features of BP-induced zebra lines in the metaphysis of an FD-affected long bone of the limbs.
Literatur
1.
Zurück zum Zitat Al Muderis M, Azzopardi T, Cundy P. Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am. 2007;89:1511–6.PubMed Al Muderis M, Azzopardi T, Cundy P. Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am. 2007;89:1511–6.PubMed
2.
Zurück zum Zitat Schenk R, Merz WA, Mühlbauer R, Russell RG, Fleisch H. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res. 1973;11:196–214.CrossRefPubMed Schenk R, Merz WA, Mühlbauer R, Russell RG, Fleisch H. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res. 1973;11:196–214.CrossRefPubMed
3.
Zurück zum Zitat Van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology. 1992;184:249–54.CrossRefPubMed Van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology. 1992;184:249–54.CrossRefPubMed
4.
Zurück zum Zitat Rauch F, Travers R, Munns C, Glorieux FH. Sclerotic metaphyseal lines in a child treated with pamidronate:histomorphometric analysis. J Bone Min Res. 2004;19:1191–3.CrossRef Rauch F, Travers R, Munns C, Glorieux FH. Sclerotic metaphyseal lines in a child treated with pamidronate:histomorphometric analysis. J Bone Min Res. 2004;19:1191–3.CrossRef
5.
Zurück zum Zitat Grissom LE, Harcke HT. Radiographic features of bisphosphonate therapy in pediatric patients. Pediatr Radiol. 2003;33:226–9.CrossRefPubMed Grissom LE, Harcke HT. Radiographic features of bisphosphonate therapy in pediatric patients. Pediatr Radiol. 2003;33:226–9.CrossRefPubMed
6.
Zurück zum Zitat Sarraf KM. Images in clinical medicine. Radiographic zebra lines from cyclical pamidronate therapy. N Engl J Med. 2011;365:e5.CrossRefPubMed Sarraf KM. Images in clinical medicine. Radiographic zebra lines from cyclical pamidronate therapy. N Engl J Med. 2011;365:e5.CrossRefPubMed
8.
Zurück zum Zitat Corsi A, Collins MT, Riminucci M, Howell PGT, Boyde A, Gehron Robey P, et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Min Res. 2003;18:1235–46.CrossRef Corsi A, Collins MT, Riminucci M, Howell PGT, Boyde A, Gehron Robey P, et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Min Res. 2003;18:1235–46.CrossRef
9.
Zurück zum Zitat Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Gehron RP. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33:434–42.CrossRefPubMed Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Gehron RP. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33:434–42.CrossRefPubMed
10.
Zurück zum Zitat Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343:953–4.CrossRefPubMed Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343:953–4.CrossRefPubMed
11.
Zurück zum Zitat Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997;12:1746–52.CrossRefPubMed Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997;12:1746–52.CrossRefPubMed
12.
Zurück zum Zitat Weinstein RS. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res. 1997;12:1314–5.CrossRefPubMed Weinstein RS. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res. 1997;12:1314–5.CrossRefPubMed
13.
Zurück zum Zitat Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, De Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune–Albright syndrome. Acta Paediatr. 2000;89:188–93.CrossRefPubMed Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, De Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune–Albright syndrome. Acta Paediatr. 2000;89:188–93.CrossRefPubMed
14.
Zurück zum Zitat Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune–Albright syndrome. J Pediatr. 2000;137:403–9.CrossRefPubMed Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune–Albright syndrome. J Pediatr. 2000;137:403–9.CrossRefPubMed
15.
Zurück zum Zitat Lane JM, Khan SN, O'Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;382:6–12.CrossRef Lane JM, Khan SN, O'Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;382:6–12.CrossRef
16.
Zurück zum Zitat Matarazzo P, Lala R, Masi G, Andreo M, Altare F, De Sanctis C. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune–Albright syndrome. J Pediatr Endocrinol Metab. 2002;3:929–37. Matarazzo P, Lala R, Masi G, Andreo M, Altare F, De Sanctis C. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune–Albright syndrome. J Pediatr Endocrinol Metab. 2002;3:929–37.
17.
Zurück zum Zitat Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003;88:4569–75.CrossRefPubMed Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003;88:4569–75.CrossRefPubMed
18.
Zurück zum Zitat Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35:235–42.CrossRefPubMed Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35:235–42.CrossRefPubMed
19.
Zurück zum Zitat Kos M, Luczak K, Godzinski J, Klempous J. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg. 2004;32:10–5.CrossRefPubMed Kos M, Luczak K, Godzinski J, Klempous J. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg. 2004;32:10–5.CrossRefPubMed
20.
Zurück zum Zitat Chan B, Zacharin M. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. J Pediatr Endocrinol Metab. 2006;19:75–80.PubMed Chan B, Zacharin M. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood. J Pediatr Endocrinol Metab. 2006;19:75–80.PubMed
21.
Zurück zum Zitat Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res. 2006;21:114–9.CrossRef Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res. 2006;21:114–9.CrossRef
22.
Zurück zum Zitat Glorieux FH, Rauch F. Medical therapy of children with fibrous dysplasia. J Bone Miner Res. 2006;21:110–3.CrossRef Glorieux FH, Rauch F. Medical therapy of children with fibrous dysplasia. J Bone Miner Res. 2006;21:110–3.CrossRef
23.
Zurück zum Zitat Boyce AM, Kelly MH, Brillante BA, et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014;99:4133–40.CrossRefPubMedPubMedCentral Boyce AM, Kelly MH, Brillante BA, et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014;99:4133–40.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Thomsen MD, Rejnmark L. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia. Calcif Tissue Int. 2014;94:384–95.CrossRefPubMed Thomsen MD, Rejnmark L. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia. Calcif Tissue Int. 2014;94:384–95.CrossRefPubMed
25.
Zurück zum Zitat Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PS, Hamdy NA. Outcome of long-term bisphosphonate therapy in McCune–Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res. 2017;32:264–76. Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PS, Hamdy NA. Outcome of long-term bisphosphonate therapy in McCune–Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res. 2017;32:264–76.
26.
Zurück zum Zitat Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med. 1991;325:1688–95.CrossRefPubMed Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med. 1991;325:1688–95.CrossRefPubMed
27.
Zurück zum Zitat Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune–Albright syndrome. Proc Natl Acad Sci U S A. 1992;89:5152–6.CrossRefPubMedPubMedCentral Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune–Albright syndrome. Proc Natl Acad Sci U S A. 1992;89:5152–6.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune–Albright syndrome. J Clin Endocrinol Metab. 1994;79:750–5.PubMed Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune–Albright syndrome. J Clin Endocrinol Metab. 1994;79:750–5.PubMed
29.
Zurück zum Zitat Bianco P, Riminucci M, Majolagbe A, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune–Albright fibrous dysplasia of bone. J Bone Miner Res. 2000;15:120–8.CrossRefPubMed Bianco P, Riminucci M, Majolagbe A, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune–Albright fibrous dysplasia of bone. J Bone Miner Res. 2000;15:120–8.CrossRefPubMed
30.
Zurück zum Zitat Bianco P, Robey PG, Wientroub S. Fibrous dysplasia. In: Glorieux FH, Pettifor J, Juppner H, editors. Pediatric bone - biology and disease. New York: Academic Press; 2003. p. 509–39.CrossRef Bianco P, Robey PG, Wientroub S. Fibrous dysplasia. In: Glorieux FH, Pettifor J, Juppner H, editors. Pediatric bone - biology and disease. New York: Academic Press; 2003. p. 509–39.CrossRef
31.
Zurück zum Zitat Marcacci M, Kon E, Zaffagnini S, Giardino R, Rocca M, Corsi A, et al. Reconstruction of extensive long-bone defects in sheep using porous hydroxyapatite sponges. Calcif Tissue Int. 1999;64:83–94.CrossRefPubMed Marcacci M, Kon E, Zaffagnini S, Giardino R, Rocca M, Corsi A, et al. Reconstruction of extensive long-bone defects in sheep using porous hydroxyapatite sponges. Calcif Tissue Int. 1999;64:83–94.CrossRefPubMed
32.
Zurück zum Zitat Boyde A, Travers R, Glorieux FH, Jones SJ. The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int. 1999;64:185–90.CrossRefPubMed Boyde A, Travers R, Glorieux FH, Jones SJ. The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int. 1999;64:185–90.CrossRefPubMed
33.
Zurück zum Zitat Boyde A, Firth EC. Musculoskeletal responses of 2-year-old thoroughbred horses to early training. 8. Quantitative back-scattered electron scanning electron microscopy and confocal fluorescence microscopy of the epiphysis of the third metacarpal bone. NZ Vet J. 2005;53:123–32.CrossRef Boyde A, Firth EC. Musculoskeletal responses of 2-year-old thoroughbred horses to early training. 8. Quantitative back-scattered electron scanning electron microscopy and confocal fluorescence microscopy of the epiphysis of the third metacarpal bone. NZ Vet J. 2005;53:123–32.CrossRef
34.
Zurück zum Zitat Stevens PM. Guided growth for angular correction: a preliminary series using a tension band plate. J Ped Orthop. 2007;27:253–9.CrossRef Stevens PM. Guided growth for angular correction: a preliminary series using a tension band plate. J Ped Orthop. 2007;27:253–9.CrossRef
35.
Zurück zum Zitat Ippolito E, Bray EW, Corsi A, et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinico-pathologic study promoted by the European Pediatric Orthopaedic Society. J Ped Orthop B. 2003;12:155–77. Ippolito E, Bray EW, Corsi A, et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinico-pathologic study promoted by the European Pediatric Orthopaedic Society. J Ped Orthop B. 2003;12:155–77.
36.
Zurück zum Zitat Corsi A, Remoli C, Riminucci M, Ippolito E, Dimitriou J. A unique case of multiple non-ossyfying fibromas with monomelic distribution and aggressive clinical course. Skelet Radiol. 2017;46:233–6.CrossRef Corsi A, Remoli C, Riminucci M, Ippolito E, Dimitriou J. A unique case of multiple non-ossyfying fibromas with monomelic distribution and aggressive clinical course. Skelet Radiol. 2017;46:233–6.CrossRef
37.
Zurück zum Zitat Wang HD, Boyce AM, Tsai JY, et al. Effects of Denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab. 2014;99:891–7.CrossRefPubMedPubMedCentral Wang HD, Boyce AM, Tsai JY, et al. Effects of Denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab. 2014;99:891–7.CrossRefPubMedPubMedCentral
Metadaten
Titel
Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune–Albright syndrome
verfasst von
Alessandro Corsi
Ernesto Ippolito
Pamela G. Robey
Mara Riminucci
Alan Boyde
Publikationsdatum
28.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 10/2017
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-017-2698-2

Weitere Artikel der Ausgabe 10/2017

Skeletal Radiology 10/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.